May 7, 2026 · Reproductive biology and endocrinology : RB&E · DOI: 10.1186/s12958-026-01547-8

SPATA22 heterozygous variants drive premature ovarian insufficiency: mechanism of granulosa cells dysfunction and therapeutic potential of N-acetylcysteine (NAC) treatment

Listen to this summary

This study investigates the role of SPATA22 heterozygous variants in driving premature ovarian insufficiency (POI) and explores the underlying mechanisms of granulosa cell dysfunction. The authors identify SPATA22 as a causative gene for POI, demonstrating that its defects lead to granulosa cell dysfunction and impaired fertility, while also showing that N-acetylcysteine (NAC) treatment can mitigate these effects and restore some ovarian function.

Lingjin Xia, Wenjing Zhang, Miao Liu, Yupei Shen, Jian Zhang, Difei Wang, Fei Wang, Zhaofeng Zhang, Yushun Zhong, Ya Huang, Guihua Li, Xin Wang, Zhikai Wang, Suying Liu, Jing Du

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play